NCT01899053View on ClinicalTrials.gov

A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

June 28, 2013

Primary Completion Date

January 31, 2017

Study Completion Date

April 30, 2018

Conditions
Advanced Nonhematologic Malignancies
Interventions
DRUG

TAK-228

TAK-228 Capsules

DRUG

TAK-117

TAK-117 Capsules

Trial Locations (5)

Unknown

Boston

Nashville

San Antonio

Barcelona

Sutton

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY